

Scientists at University College London have developed the first targeted therapy for children with genetic kidney disease, a condition that currently has no treatment and often leads to lifelong dialysis or transplant.

The precision RNA treatment delivered directly to tiny kidney filters reduced protein leakage and scarring in early tests.

Want to know more?